Janus Henderson Forty Fund’s Updates on Eli Lilly and Company (LLY)

What: Janus Henderson Forty Fund has updated its holdings in Eli Lilly and Company (LLY) as of March 2026.
Why: The fund has increased its stake in LLY by **0.15%**, now holding **4.22%** of the company's outstanding shares.
Signal: This move indicates the fund's confidence in LLY's growth prospects, particularly in its oncology and immunology segments.
Target: Janus Henderson Forty Fund is likely targeting LLY's strong pipeline and recent product approvals, which are expected to drive revenue growth.
Risk: However, the fund's increased exposure to LLY also amplifies its risk, given the company's reliance on a few key products and potential regulatory challenges.